MedTrace Logo

Efficacy of Voluven® for the Prevention of Hypotension During Spinal Anesthesia for Cesarean Section

NCT00694343 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 167

Last updated 2012-05-31

No results posted yet for this study

Summary

The aim of the study is to evaluate the efficacy of Voluven® in the prevention of maternal hypotension in women undergoing spinal anesthesia for cesarean section

Conditions

Interventions

DRUG

HES 130/0.4 (6%) in sodium chloride (solution for infusion)

500 mL of HES 130/0.4 (6%) and 500 mL Ringer's Lactate Solution

DRUG

Ringer's Lactate solution

1000 mL Ringer's Lactate solution

Sponsors & Collaborators

  • Fresenius Kabi

    lead INDUSTRY

Principal Investigators

  • Frederic Mercier, Professor · Hôpital Béclère, Service Anesthésie-Réanimation, 157 Rue de la Porte de Trivaux, 92140 Clamart, France

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2009-12-31
Completion
2010-06-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00694343 on ClinicalTrials.gov